Antitrust enforcers are raising red flags about competition in health care as lawmakers ramp up their focus on the same issues.
Two Democratic Federal Trade Commission commissioners spoke about a need for more information about changes in the health-care market at different events May 14.
Commissioner Rebecca Kelly Slaughter said the FTC should systematically review past mergers with a focus on how deals across healthy industry sectors may have changed the competitive landscape. Meanwhile, Commissioner Rohit Chopra said he wants to spend more time examining the shadowy system of pharmaceutical rebates.
Their remarks come as the Senate Judiciary Committee plans...
For more stories, analysis and expertiseOR Request Trial
(Updates with additional detail in the ninth and 10th paragraphs.)